Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2018-2027 (USD Billion)
1.2.1. Companion Diagnostic Technologies Market, by Region, 2018-2027 (USD Billion)
1.2.2. Companion Diagnostic Technologies Market, by Indication, 2018-2027 (USD Billion)
1.2.3. Companion Diagnostic Technologies Market, by Technology, 2018-2027 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Companion Diagnostic Technologies Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Companion Diagnostic Technologies Market Dynamics
3.1. Companion Diagnostic Technologies Market Impact Analysis (2018-2027)
3.1.1. Market Drivers
3.1.2. Market Challenges
3.1.3. Market Opportunities
Chapter 4. Global Companion Diagnostic Technologies Market Industry Analysis
4.1. Porters 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porters 5 Force Model (2017-2027)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
Chapter 5. Global Companion Diagnostic Technologies Market, by Indication
5.1. Market Snapshot
5.2. Global Companion Diagnostic Technologies Market by Indication, Performance - Potential Analysis
5.3. Global Companion Diagnostic Technologies Market Estimates & Forecasts by Indication 2017-2027 (USD Billion)
5.4. Companion Diagnostic Technologies Market, Sub Segment Analysis
5.4.1. Oncology
5.4.2. Cardiovascular
5.4.3. Central Nervous System
5.4.4. Auto immune & Inflammation
5.4.5. Virology
5.4.6. Others
Chapter 6. Global Companion Diagnostic Technologies Market, by Technology
6.1. Market Snapshot
6.2. Global Companion Diagnostic Technologies Market by Technology, Performance - Potential Analysis
6.3. Global Companion Diagnostic Technologies Market Estimates & Forecasts by Technology 2017-2027 (USD Billion)
6.4. Companion Diagnostic Technologies Market, Sub Segment Analysis
6.4.1. Immunohistochemistry
6.4.2. Molecular diagnostics
Chapter 7. Global Companion Diagnostic Technologies Market, Regional Analysis
7.1. Companion Diagnostic Technologies Market, Regional Market Snapshot
7.2. North America Companion Diagnostic Technologies Market
7.2.1. U.S. Companion Diagnostic Technologies Market
7.2.1.1. Indication breakdown estimates & forecasts, 2017-2027
7.2.1.2. Technology breakdown estimates & forecasts, 2017-2027
7.2.2. Canada Companion Diagnostic Technologies Market
7.3. Europe Companion Diagnostic Technologies Market Snapshot
7.3.1. U.K. Companion Diagnostic Technologies Market
7.3.2. Germany Companion Diagnostic Technologies Market
7.3.3. France Companion Diagnostic Technologies Market
7.3.4. Spain Companion Diagnostic Technologies Market
7.3.5. Italy Companion Diagnostic Technologies Market
7.3.6. Rest of Europe Companion Diagnostic Technologies Market
7.4. Asia-Pacific Companion Diagnostic Technologies Market Snapshot
7.4.1. China Companion Diagnostic Technologies Market
7.4.2. India Companion Diagnostic Technologies Market
7.4.3. Japan Companion Diagnostic Technologies Market
7.4.4. Australia Companion Diagnostic Technologies Market
7.4.5. South Korea Companion Diagnostic Technologies Market
7.4.6. Rest of Asia Pacific Companion Diagnostic Technologies Market
7.5. Latin America Companion Diagnostic Technologies Market Snapshot
7.5.1. Brazil Companion Diagnostic Technologies Market
7.5.2. Mexico Companion Diagnostic Technologies Market
7.6. Rest of The World Companion Diagnostic Technologies Market
Chapter 8. Competitive Intelligence
8.1. Top Market Strategies
8.2. Company Profiles
8.2.1. Qiagen
8.2.1.1. Key Information
8.2.1.2. Overview
8.2.1.3. Financial (Subject to Data Availability)
8.2.1.4. Product Summary
8.2.1.5. Recent Developments
8.2.2. Dako (Agilent Technologies)
8.2.3. Roche Diagnostics
8.2.4. Abbott Laboratories, Inc.
8.2.5. BioMerieux
8.2.6. Ventana Medical Systems
8.2.7. Myriad Genetics, Inc.
8.2.8. Resonance Health Ltd.
8.2.9. Leica Microsystems
8.2.10. Life Technologies
Chapter 9. Research Process
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.2. Research Attributes
9.3. Research Assumption